Though variable expression levels were observed in the different subsets of AML, MELK expression level was relatively higher in AML with a complex karyotypes, t(6,9) and del(5q)/−5, all of which are associated with chemotherapy-resistant disease and inferior clinical outcome. The gene discussed is MELK; the disease is acute myeloid leukemia.